medroxyprogesterone acetate
These highlights do not include all the information needed to use MEDROXYPROGESTERONE ACETATE (MPA) Injectable Suspension, USP safely and effectively. See full prescribing information for MPA INJECTABLE SUSPENSION, USP. MEDROXYPROGESTERONE ACETATE (MPA) Injectable Suspension, USP, for intramuscular use Initial U.S. Approval: 1959
987496bf-b4b0-409b-b745-f52ed0871f4e
HUMAN PRESCRIPTION DRUG LABEL
Oct 21, 2021
Prasco Laboratories
DUNS: 065969375
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
medroxyprogesterone acetate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (9)
medroxyprogesterone acetate
Product Details
FDA regulatory identification and product classification information